ATE524168T1 - Transdermales system für vareniclin - Google Patents

Transdermales system für vareniclin

Info

Publication number: ATE524168T1
Authority: AT; Austria
Prior art keywords: varenicline; transdermal system; transdermal
Prior art date: 2005-07-26

Application number

AT06779913T

Other languages

English (en)

Inventor

Barbara Johnson

Carl ZIEGLER

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-07-26

Filing date

2006-07-13

Publication date

2011-09-15

2006-07-13 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2011-09-15 Application granted granted Critical

2011-09-15 Publication of ATE524168T1 publication Critical patent/ATE524168T1/de

Links

229940100640 transdermal system Drugs 0.000 title 1
JQSHBVHOMNKWFT-DTORHVGOSA-N varenicline Chemical compound C12=CC3=NC=CN=C3C=C2[C@H]2C[C@@H]1CNC2 JQSHBVHOMNKWFT-DTORHVGOSA-N 0.000 title 1
229960004751 varenicline Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4995—Pyrazines or piperazines forming part of bridged ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Addiction (AREA)
Psychiatry (AREA)
Dispersion Chemistry (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Psychology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Hospice & Palliative Care (AREA)
Child & Adolescent Psychology (AREA)
Anesthesiology (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

AT06779913T 2005-07-26 2006-07-13 Transdermales system für vareniclin ATE524168T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US70296105P	2005-07-26	2005-07-26
PCT/IB2006/002081 WO2007012963A1 (en)	2005-07-26	2006-07-13	Transdermal system for varenicline

Publications (1)

Publication Number	Publication Date
ATE524168T1 true ATE524168T1 (de)	2011-09-15

Family

ID=37175751

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT06779913T ATE524168T1 (de)	2005-07-26	2006-07-13	Transdermales system für vareniclin

Country Status (17)

Country	Link
US (1)	US20110086086A1 (de)
EP (1)	EP1909773B1 (de)
JP (1)	JP2007031436A (de)
KR (2)	KR20080018278A (de)
CN (2)	CN101232876A (de)
AR (1)	AR054507A1 (de)
AT (1)	ATE524168T1 (de)
AU (1)	AU2006273772A1 (de)
BR (1)	BRPI0614171A2 (de)
CA (1)	CA2616695C (de)
IL (1)	IL188268A0 (de)
MX (1)	MX2007016458A (de)
NZ (1)	NZ564685A (de)
RU (1)	RU2388461C2 (de)
TW (1)	TWI327472B (de)
WO (1)	WO2007012963A1 (de)
ZA (1)	ZA200800032B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102007058504A1 (de) *	2007-12-05	2009-07-09	Acino Ag	Transdermales therapeutisches System mit einem Gehalt an einem Modulator für nikotinische Acetylcholinrezeptoren (nAChR)
ES2648197T3 (es) *	2008-02-27	2017-12-29	Hisamitsu Pharmaceutical Co., Inc.	Parche medicado
US9155725B2 (en) *	2008-02-27	2015-10-13	Hisamitsu Pharmaceutical Co., Inc.	Adhesive skin patch and packaged product
WO2009111623A2 (en) *	2008-03-06	2009-09-11	Dr. Reddy's Laboratories Ltd.	Amorphous varenicline tartrate
US8039620B2 (en)	2008-05-22	2011-10-18	Teva Pharmaceutical Industries Ltd.	Varenicline tosylate, an intermediate in the preparation process of varenicline L-tartrate
JP2010285415A (ja) *	2009-06-15	2010-12-24	Hisamitsu Pharmaceut Co Inc	バレニクリン又は薬学的に許容されるバレニクリン酸付加塩を含有する経皮薬物送達システムの包装体
US8178537B2 (en)	2009-06-22	2012-05-15	Teva Pharmaceutical Industries Ltd.	Solid state forms of varenicline salts and processes for preparation thereof
US20110274628A1 (en)	2010-05-07	2011-11-10	Borschke August J	Nicotine-containing pharmaceutical compositions
CN102541332A (zh) *	2010-12-30	2012-07-04	联咏科技股份有限公司	单击手势判断方法、触控感应控制芯片、触控及电脑系统
US20130053668A1 (en) *	2011-08-26	2013-02-28	Compose Element Limited	Kit and method for detecting blood sugar
WO2015025718A1 (ja) *	2013-08-23	2015-02-26	久光製薬株式会社	貼付剤
CN111956803B (zh)	2014-10-20	2025-10-31	奥伊斯特普安生物制药公司	治疗眼部病状的方法
CN114533737B (zh)	2016-04-07	2024-05-31	奥伊斯特普安生物制药公司	治疗眼部病状的方法
KR102771688B1 (ko) *	2016-09-07	2025-02-20	에스케이케미칼 주식회사	바레니클린의 경피 투여를 위한 약학 제제
GB2561333B (en)	2017-02-17	2020-06-03	Bo Soederpalm	Treatment of alcohol use disorder
US10912734B2 (en) *	2018-05-16	2021-02-09	Cipla Limited	Depot formulation
CN111135087A (zh) *	2020-01-09	2020-05-12	范小玲	一种溶剂型透皮贴的工业化制备方法
WO2022140480A1 (en) *	2020-12-23	2022-06-30	GameChanger Patch Co.	Transdermal patches for hangover minimization and/or recovery, and/or sleep improvement
CN113116814A (zh) *	2021-04-01	2021-07-16	江苏山信药业有限公司	一种伐尼克兰透皮溶液剂及其制备方法和其应用
CN116370439A (zh) *	2022-04-01	2023-07-04	江苏山信药业有限公司	一种伐尼克兰透皮贴剂及其制备方法和其应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US219196A (en) *		1879-09-02		Improvement in bretzel-machines
US127531A (en) *		1872-06-04		Improvement in car-starters
US4910020A (en) *	1988-10-21	1990-03-20	Macrochem Corporation	Transdermal medicator
EP0394429B1 (de) *	1988-10-27	1996-01-10	Schering Aktiengesellschaft	Mittel zur transdermalen applikation enthaltend gestoden
DE3910578A1 (de) *	1989-03-29	1990-10-04	Schering Ag	Mittel zur transdermalen applikation enthaltend gestoden
US5008110A (en) *	1988-11-10	1991-04-16	The Procter & Gamble Company	Storage-stable transdermal patch
HUT74949A (en) *	1993-09-10	1997-03-28	Cytomed	Epibatidine and derivatives thereof as cholinergic receptor agonists and antagonists
US5552399A (en) *	1994-11-02	1996-09-03	Janssen Pharmaceutica N.V.	Substituted tetracyclic azepine derivatives
US6365178B1 (en) *	1996-09-06	2002-04-02	Watson Pharmaceuticals, Inc.	Method of making pressure sensitive adhesive matrix patches for transdermal drug delivery using hydrophilic salts of drugs and hydrophobic pressure sensitive adhesive dispersions
IT1294748B1 (it) *	1997-09-17	1999-04-12	Permatec Tech Ag	Formulazione per un dispositivo transdermico
WO1999032095A1 (en) *	1997-12-22	1999-07-01	Alza Corporation	Rate controlling membranes for controlled drug delivery devices
EP1117389A1 (de) *	1998-09-08	2001-07-25	TheraTech, Inc.	Verfahren zur herstellung von druckempfindlichen klebepflastern enthaltend hydrophyle wirkstoffsalze
OA12599A (en) *	2001-05-14	2006-06-08	Pfizer Prod Inc	Tartrate salts of 5,8, 14-triazatetracyclo Ä10.3.1.o2,11.o4.9Ü-hexadeca2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof.
US20030008892A1 (en) *	2001-07-09	2003-01-09	Pfizer Inc.	Pharmaceutical composition and method of modulating cholinergic function in a mammal
DE10141651B4 (de) *	2001-08-24	2007-02-15	Lts Lohmann Therapie-Systeme Ag	Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung
MXPA04003192A (es) *	2001-11-29	2004-07-27	Pfizer Prod Inc	Sales de acido succinico de 5, 7, 14-triazatetraciclo ?10.3.1.02,11.04,9? -hexadeca-2(11), 3, 5, 7, 9-pentaeno y composiciones farmacetucias de las mismas.
IL161857A0 (en) *	2001-11-30	2005-11-20	Pfizer Prod Inc	Pharmaceutical compositions of 5,7,14-triazatetracycloÄ10.3.1.0(2,11).0(4,9)Ü-hexadeca-2(11)3,5,7,9-pentaene
US6676961B1 (en) *	2002-03-06	2004-01-13	Automated Carrier Technologies, Inc.	Transdermal patch assembly
NZ537003A (en) *	2002-07-18	2008-03-28	Cytos Biotechnology Ag	Hapten-carrier conjugates comprising virus like particles and uses thereof
BRPI0515932A (pt) *	2004-10-15	2008-08-12	Pfizer Prod Inc	composições e métodos para distribuição intranasal, bucal, sublingual e pulmonar de vareniclina
AU2005302669A1 (en) *	2004-10-27	2006-05-11	Neurogen Corporation	Diaryl ureas as CB1 antagonists
JP2008526827A (ja) *	2005-01-07	2008-07-24	ファイザー・プロダクツ・インク	５，８，１４−トリアザテトラシクロ［１０．３．１．０２，１１．０４，９］−ヘキサデカ−２（１１），３，５，７，９−ペンタエンの速崩壊性投与形態

2006
- 2006-06-13 US US11/574,045 patent/US20110086086A1/en not_active Abandoned
- 2006-07-13 KR KR1020087002048A patent/KR20080018278A/ko not_active Withdrawn
- 2006-07-13 MX MX2007016458A patent/MX2007016458A/es active IP Right Grant
- 2006-07-13 EP EP06779913A patent/EP1909773B1/de not_active Not-in-force
- 2006-07-13 BR BRPI0614171-4A patent/BRPI0614171A2/pt not_active IP Right Cessation
- 2006-07-13 CN CNA2006800276994A patent/CN101232876A/zh active Pending
- 2006-07-13 KR KR1020097024108A patent/KR20090125294A/ko not_active Ceased
- 2006-07-13 CN CN201010115865A patent/CN101862310A/zh active Pending
- 2006-07-13 CA CA2616695A patent/CA2616695C/en not_active Expired - Fee Related
- 2006-07-13 WO PCT/IB2006/002081 patent/WO2007012963A1/en not_active Ceased
- 2006-07-13 NZ NZ564685A patent/NZ564685A/en not_active IP Right Cessation
- 2006-07-13 RU RU2008101926/15A patent/RU2388461C2/ru not_active IP Right Cessation
- 2006-07-13 AT AT06779913T patent/ATE524168T1/de not_active IP Right Cessation
- 2006-07-13 AU AU2006273772A patent/AU2006273772A1/en not_active Abandoned
- 2006-07-25 AR ARP060103197A patent/AR054507A1/es not_active Application Discontinuation
- 2006-07-25 JP JP2006201490A patent/JP2007031436A/ja active Pending
- 2006-07-25 TW TW095127076A patent/TWI327472B/zh not_active IP Right Cessation
2007
- 2007-12-19 IL IL188268A patent/IL188268A0/en unknown
2008
- 2008-01-02 ZA ZA200800032A patent/ZA200800032B/xx unknown

Also Published As

Publication number	Publication date
NZ564685A (en)	2010-10-29
TWI327472B (en)	2010-07-21
US20110086086A1 (en)	2011-04-14
WO2007012963A1 (en)	2007-02-01
AR054507A1 (es)	2007-06-27
BRPI0614171A2 (pt)	2011-03-15
EP1909773B1 (de)	2011-09-14
AU2006273772A1 (en)	2007-02-01
CN101862310A (zh)	2010-10-20
CA2616695A1 (en)	2007-02-01
RU2008101926A (ru)	2009-09-10
CN101232876A (zh)	2008-07-30
TW200731974A (en)	2007-09-01
IL188268A0 (en)	2008-04-13
CA2616695C (en)	2011-07-05
KR20080018278A (ko)	2008-02-27
RU2388461C2 (ru)	2010-05-10
EP1909773A1 (de)	2008-04-16
MX2007016458A (es)	2008-03-07
ZA200800032B (en)	2009-09-30
JP2007031436A (ja)	2007-02-08
KR20090125294A (ko)	2009-12-04

Legal Events

Date	Code	Title	Description
2012-03-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
IL250734A0 (en)	2017-04-30	Transdermal therapeutic system
IL188268A0 (en)	2008-04-13	Transdermal system for varenicline
DK1889198T3 (da)	2015-02-09	Farma-informatiksystem
DE602005009649D1 (de)	2008-10-23	Wagensystem
DE602007012976D1 (de)	2011-04-21	Lenksystem
DE502006008209D1 (de)	2010-12-16	Abgasanlage
EP1886443A4 (de)	2011-03-09	Effiziente wiederherstellungsarchitektur für verlustentkoppelte tcp
EP2006683A4 (de)	2009-09-23	Bestimmungsverfahren für menschliches megalin
DE502006007103D1 (de)	2010-07-15	Anschluss-system
ATE552752T1 (de)	2012-04-15	Ausziehführungssystem für schubladen
ATE519404T1 (de)	2011-08-15	Siebträgersystem
ITFI20050094A1 (it)	2006-11-07	Opercolatrice perfezionata
JP2006340726A5 (ja)	2007-04-12	再生
JP2006340727A5 (ja)	2007-04-12	再生
DE602006014117D1 (de)	2010-06-17	Antriebssystem für landeklappe
DK1943388T3 (da)	2015-06-22	Køretøjs-indtrængningshæmmere
DE602006004669D1 (de)	2009-02-26	Abgassystem
DE602006016290D1 (de)	2010-09-30	Fahrtenschreiber
DE602007004210D1 (de)	2010-02-25	Haltesystem
DE502007003396D1 (de)	2010-05-20	Sbesondere für rakeldruckverfahren
DE602006005871D1 (de)	2009-05-07	Abgasanlage
BRPI0716123A2 (pt)	2013-09-17	sistema de encadernaÇço
FI20050681A0 (fi)	2005-06-22	Paikoitusmenetelmä
SE0502776L (sv)	2007-06-17	Telematiksystem
LU91233B1 (de)	2007-10-15	Laderaumsystem